Drugs / HK-001
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT03651349 | Feb 2021 → Dec 2025 overdue | amyotrophic lateral sclerosis | Everfront Biotech Co., Ltd. | Active not recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | HK-001 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03651349 ↗ |